When the possibilities for disease prevention are endless, challenges are close behind

July 8th 2025

Food Insecurity and the Dangers of Infant Formula Dilution

A newly-published study identified specific groups of higher-risk children that could benefit most from monoclonal antibodies.

January 30th 2023

US measles cases reach new record high since eradication declaration in 2000

Demystifying Infant Formula

A week into July 2025, the total reported cases in the United States have surpassed the peak of 1274 cases recorded for all 2019.

October 11th 2022

FDA approves sebetralstat as first and only on-demand treatment for HAE

Weekly review: Label changes to maralixibat, pediatric mental health data, and more

Though the original target action date was not met by the FDA, KalVista's sebetralstat is now approved to treat HAE in patients 12 years and older.

July 5th 2025

Specific groups with chronic conditions who could most benefit from RSV prophylaxis

Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.

Related Content

July 8th 2025

Food Insecurity and the Dangers of Infant Formula Dilution

A newly-published study identified specific groups of higher-risk children that could benefit most from monoclonal antibodies.

January 30th 2023

US measles cases reach new record high since eradication declaration in 2000

Demystifying Infant Formula

A week into July 2025, the total reported cases in the United States have surpassed the peak of 1274 cases recorded for all 2019.

October 11th 2022

FDA approves sebetralstat as first and only on-demand treatment for HAE

Weekly review: Label changes to maralixibat, pediatric mental health data, and more

Though the original target action date was not met by the FDA, KalVista's sebetralstat is now approved to treat HAE in patients 12 years and older.

July 5th 2025